1-14 of 14
Yaël Cohen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Surzetoclax (ABBV-453) in combination with daratumumab and dexamethasone in biomarker-selected patients with Relapsed/Refractory multiple myeloma: A Phase 1/2, multicenter, open-label platform study

Free
John McKay, Hang Quach, Matthew Pianko, Shonali Midha, Jorge Chaves, Kevin Kelly, Hila Magen, Yaël Cohen, Moshe Gatt, Noa Lavi, Adeel Khan, Silvia Ling, Iuliana Vaxman, Sabrina Browning, Xin Chen, Michelle Gillard, Anita Szoke, Lynne Neumayr, Maria Semerjian, Agostino Pozzi, Saad Usmani
Journal: Blood
Blood (2025) 146 (Supplement 1): 5844.
https://doi.org/10.1182/blood-2025-5844
Published: 2025
Journal Articles

Daratumumab monotherapy versus active monitoring in patients with high-risk smoldering multiple myeloma: Aquila outcomes based on mayo 2018/IMWG 2020 risk stratification, IMWG 2020 plus cytogenetic criteria, and age

Free
Peter Voorhees, Meletios Dimopoulos, Yaël Cohen, Fredrik Schjesvold, Vania Hungria, Irwindeep Sandhu, Jindriska Lindsay, Ross Baker, Kenshi Suzuki, Hiroshi Kosugi, Mark-David Levin, Meral Beksac, Keith Stockerl-Goldstein, Hila Magen, Albert Oriol, Gabor Mikala, Gonzalo Garate, Koen Theunissen, Ivan Špička, Anne Mylin, Simon Hallam, Sara Bringhen, Katarina Uttervall, Bartosz Pula, Abdullah Khan, Eva Medvedova, J Christine Ye, Andrew Cowan, Philippe Moreau, María-Victoria Mateos, Hartmut Goldschmidt, Diego Vieyra, Ashta Raval, Linlin Sha, Liang Li, Els Rousseau, Robyn Dennis, Robin Carson, S. Vincent Rajkumar
Journal: Blood
Blood (2025) 146 (Supplement 1): 372.
https://doi.org/10.1182/blood-2025-372
Published: 2025
Journal Articles

Summary analysis of the phase 1a/b study with HBI0101, an academic anti-BCMA chimeric antigen receptor T-cell (CART) for relapsed/refractory multiple myeloma

Free
Eyal Lebel, Nathalie Asherie, Shlomit Kfir-Erenfeld, Batia Avni, Sigal Grisariu, Shlomo Elias, Eran Zimran, Vladimir Vainstein, Shlomzion Aumann, Miri Assayag, Marina Krizhevskaya, Ekaterina Dikhter, Marjorie Pick, Yaël Cohen, Irit Avivi, Cyrille Cohen, Moshe Gatt, Polina Stepensky
Journal: Blood
Blood (2025) 146 (Supplement 1): 2379.
https://doi.org/10.1182/blood-2025-2379
Published: 2025
Journal Articles

Comparative efficacy of ciltacabtagene autoleucel (cilta-cel) versus belantamab mafodotin (belamaf), bortezomib, and dexamethasone and versus belamaf, pomalidomide, and dexamethasone in patients with relapsed / refractory multiple myeloma (RRMM) previously treated with 1–3 prior lines of therapy using a matching-adjusted indirect comparison

Free
Christopher Strouse, Surbhi Sidana, Rafael Fonseca, Joaquin Martinez-Lopez, Yaël Cohen, Binod Dhakal, Murali Janakiram, Suzy Van Sanden, João Mendes, Joris Diels, Seina Lee, Sundar Jagannath
Journal: Blood
Blood (2025) 146 (Supplement 1): 4046.
https://doi.org/10.1182/blood-2025-4046
Published: 2025
Journal Articles

Updated analysis of survival and treatment evolution in european multiple myeloma patients (2012–2023) across 7 countries from the honeur network

Free
Javier de la Rubia, Roman Hajek, Jiri Minarik, Stork Martin, Alexandra Jungova, Mamta Garg, Yaël Cohen, Tamir Shragai, Irit Avivi, Svetlana Trestman, Natan Melamed, Marc Maynadié, Adrien Guilloteau, Claudio Cerchione, Alice Andalò, Nicola Gentili, Ilaria Massa, Delia Cangini, Miguel Angel Mayer, Juan Manuel Ramírez-Anguita, Angela Leis, Ceri Bygrave, Hannah Belcher, Blanca Gros Otero, Giselle Lostaunau Costa, Nolen J. Perualila, Wout Vekemans, Michel Van Speybroeck, Joris Diels, Guillaume Azarias, Markus Rückert
Journal: Blood
Blood (2025) 146 (Supplement 1): 2803.
https://doi.org/10.1182/blood-2025-2803
Published: 2025
Journal Articles

Talquetamab induces deep responses in heavily pre-treated patients with systemic light-chain amyloidosis

Free
Mohamad Ganayem, Moshe Gatt, Yaël Cohen, Irit Avivi, Tamir Shragai
Journal: Blood
Blood (2025) 146 (Supplement 1): 7491.
https://doi.org/10.1182/blood-2025-7491
Published: 2025
Journal Articles

Safety and efficacy of talquetamab + teclistamab in patients with Relapsed/Refractory multiple myeloma from Phase 1b of redirectt-1: Results with an extended median follow-up of 3 years

Free
María-Victoria Mateos, Hila Magen, Moshe Gatt, Michael Sebag, Kihyun Kim, Chang-Ki Min, Enrique Ocio, Sung-Soo Yoon, Michael Chu, Paula Rodriguez-Otero, Irit Avivi, Natalia Quijano Carde, Maria Krevvata, Todd Henninger, Payal Thakkar, Mariacristina Festa, Lin Huang, Jiangxiu Zhou, Mikihiro Takamoto, Lixia Pei, Jiashen Lu, Carmela Maffucci, Emma Scott, Albert Oriol, Daniel Morillo, Yaël Cohen
Journal: Blood
Blood (2025) 146 (Supplement 1): 701.
https://doi.org/10.1182/blood-2025-701
Published: 2025
Journal Articles

Efficacy and safety of talquetamab + teclistamab in patients with Relapsed/Refractory multiple myeloma and extramedullary disease: Updated Phase 2 results from the redirectt-1 study with extended follow-up

Free
Saad Usmani, Shaji Kumar, María-Victoria Mateos, J Christine Ye, Shebli Atrash, Hila Magen, Hang Quach, Michael Chu, Suzanne Trudel, Joshua Richter, Paula Rodriguez-Otero, Hun Chuah, Moshe Gatt, Eva Medvedova, Shahzad Raza, Dok Hyun Yoon, Tadao Ishida, Jeffrey Matous, Laura Rosiñol Dachs, Koichi Onodera, Carmela Maffucci, Emma Scott, Christoph Heuck, Jing Zhang, Todd Henninger, Lisa O'Rourke, Payal Thakkar, Mariacristina Festa, Lin Huang, Jiangxiu Zhou, Mikihiro Takamoto, Lixia Pei, Jiashen Lu, Nicholas Au, Maria Krevvata, Yaël Cohen
Journal: Blood
Blood (2025) 146 (Supplement 1): 698.
https://doi.org/10.1182/blood-2025-698
Published: 2025
Journal Articles

Trial in progress: QUINTESSENTIAL-2—a phase 3 study of arlocabtagene autoleucel versus standard of care in adult patients with relapsed and refractory multiple myeloma (RRMM) exposed to lenalidomide

Free
Eyal Lebel, Ahmed Abdulgawad, Stefania Bramanti, Gonzalo Garate, Phoebe Joy Ho, Mikko Keränen, Yaël Cohen, Maja Vase, Amit Khot, Ida Bruun Kristensen, Richard LeBlanc, Cindy Lee, Wojciech Legiec, Hila Magen, María-Victoria Mateos, Danielle Oh, Ludek Pour, Natalia Schutz, Alexandros Spyridonidis, Katja Weisel, Jan Zaucha, Sarah Larson, Asya Varshasvsky, Kimberly Grazioli, Debashree Basudhar, Hongxiang Hu, Ya Meng, Lamis Eldjerou, Susan Bal, Simon Harrison, Rakesh Popat, Marc Raab, Paula Rodriguez-Otero
Journal: Blood
Blood (2025) 146 (Supplement 1): 2302.
https://doi.org/10.1182/blood-2025-2302
Published: 2025
Journal Articles

Daratumumab Monotherapy for Patients with Intermediate or High-Risk Smoldering Multiple Myeloma (SMM): Centaurus, a Randomized, Open-Label, Multicenter Phase 2 Study

Free
Craig C Hofmeister, MDMPH, Ajai Chari, Yael Cohen, Andrew Spencer, MD, Peter M. Voorhees, MD, Jane Estell, Christopher P. Venner, Irwindeep Sandhu, Matthew W Jenner, Cathy Williams, Michele Cavo, MD, Niels WCJ Van De Donk, Meral Beksac, Steven Kuppens, Rajesh Bandekar, Tobias Neff, Christoph Heuck, Ming Qi, Hartmut Goldschmidt, MD, Ola Landgren, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 510.
https://doi.org/10.1182/blood.V130.Suppl_1.510.510
Published: 2017
Journal Articles

Treatment Patterns and Clinical Outcomes in High-Risk Multiple Myeloma Patients Carrying the 17p Deletion: A Multi-Center Retrospective Observational Study

Free
Yael Cohen, MD, Moshe E. Gatt, MD, Noa Lavi, MD, Chezi Ganzel, Hila Magen, MD, Irit Avivi, MD, Tamar Tadmor, MD, Celia Suriu, MD, Osnat Jarchowsky Dolberg, Amitai Papushado, MD, Svetlana Trestman, MD, Ron Ram, MD
Journal: Blood
Blood (2016) 128 (22): 4510.
https://doi.org/10.1182/blood.V128.22.4510.4510
Published: 2016
Journal Articles

Primary Plasma Cell Leukemia Has a Poor Prognosis Even in the Era of Novel Agents - a Multicenter Case Series

Free
Chezi Ganzel, Ory Rouvio, MD, Hila Magen, MD, Osnat Jarchowsky, Irit Avivi, MD, Katrin Herzog, Cohen Yossi, Tamar Tadmor, MD, Netanel A Horowitz, MD, Merav Leiba, MD, Arnon Nagler, MD MSc, Yael Cohen, MD, Shlomo Bulvik, MD, Dina Ben Yehuda, MD, Jacob M. Rowe, MD, Moshe E. Gatt, MD
Journal: Blood
Blood (2016) 128 (22): 5699.
https://doi.org/10.1182/blood.V128.22.5699.5699
Published: 2016
Journal Articles

The natural history of refractory idiopathic thrombocytopenic purpura

Free
Benjamin Djulbegovic, Yael Cohen
Journal: Blood
Blood (2001) 98 (7): 2282–2283.
https://doi.org/10.1182/blood.V98.7.2282
Published: 2001
Journal Articles

Extensive Venous and Arterial Thrombosis Associated With an Inhibitor to Activated Protein C

Free
Ariella Zivelin, Sanford Gitel, John H. Griffin, Xiao Xu, Jose A. Fernandez, Uri Martinowitz, Yael Cohen, Hillel Halkin, Uri Seligsohn, Aida Inbal
Journal: Blood
Blood (1999) 94 (3): 895–901.
https://doi.org/10.1182/blood.V94.3.895.415k01_895_901
Published: 1999